Leaderboards/Allergic Rhinitis and Sensitization

Allergic Rhinitis and Sensitization

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Thomas Plum
German Cancer Research Center
2
Christian Woehlk
Bispebjerg Hospital
3
Oliver Langselius
Centre international de recherche sur le cancer
4
Shaimaa Albloushi
Ministry of Health
5
Bin Zhang
Tessa Therapeutic (Singapore)
6
Rifat Sadik
Jahangirnagar University
7
Rebecca Riedl
Jena University Hospital
8
Eva Conde
Inserm
9
Qin Geng
Nanchang University
10
Natalia Alkon
Medical University of Vienna

Papers

1
Publication in Frontiers in Immunology (2024) [57 citations, W4394757819]
Frontiers in Immunology|2024
57 cit.
2
Engineered EVs with pathogen proteins: promising vaccine alternatives to LNP-mRNA vaccines
Journal of Biomedical Science|2024
31 cit.
3
Publication in Journal of Allergy and Clinical Immunology (2024) [15 citations, W4402527560]
Journal of Allergy and Clinical Immunology|2024
15 cit.
4
Publication in Allergy (2025) [4 citations, W4414702872]
Allergy|2025
4 cit.
5
Publication in Journal of Investigative Dermatology (2024) [W4400825033]
Journal of Investigative Dermatology|2024
0 cit.
6
Publication in European Journal of Cancer (2024) [W4403244788]
European Journal of Cancer|2024
0 cit.
7
Publication in Journal of Investigative Dermatology (2025) [W4416076459]
Journal of Investigative Dermatology|2025
0 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Thomas Marichal
University of Liège
2
Nicolas Gaudenzio
Centre National de la Recherche Scientifique
3
Leda Mannent
Sanofi (France)
4
Iris Stappen
University of Vienna
5
Allison Crimmins
National Oceanic and Atmospheric Administration
6
José Oteros
University of Córdoba
7
Aleksandra Wardzyńska
Medical University of Lodz
8
Narayan Nair
Center for Biologics Evaluation and Research
9
Qi Ying Lean
Universiti Teknologi MARA
10
Alejandro Molina‐Leyva
Universidad de Granada

Papers

1
Landscape of mast cell populations across organs in mice and humans
The Journal of Experimental Medicine|2023
136 cit.
2
MafB-restricted local monocyte proliferation precedes lung interstitial macrophage differentiation
Nature Immunology|2023
112 cit.
3
Recruited atypical Ly6G <sup>+</sup> macrophages license alveolar regeneration after lung injury
Science Immunology|2024
52 cit.
4
Potential Benefits of the Mediterranean Diet and Physical Activity in Patients with Hidradenitis Suppurativa: A Cross-Sectional Study in a Spanish Population
Nutrients|2022
40 cit.
5
Short-Term Effectiveness, Safety, and Potential Predictors of Response of Secukinumab in Patients with Severe Hidradenitis Suppurativa Refractory to Biologic Therapy: A Multicenter Observational Retrospective Study
Dermatology and Therapy|2023
30 cit.
6
Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results
Annals of Otology Rhinology & Laryngology|2023
30 cit.
7
Switching from Adalimumab Originator to Biosimilar: Clinical Experience in Patients with Hidradenitis Suppurativa
Journal of Clinical Medicine|2022
27 cit.
8
Sexual Dysfunction and Quality of Life in Patients with Hidradenitis Suppurativa and Their Partners
International Journal of Environmental Research and Public Health|2022
27 cit.
9
Journey of monocytes and macrophages upon influenza A virus infection
Current Opinion in Virology|2024
24 cit.
10
Insights into the Window of Opportunity and Outcome Measures in Patients with Moderate to Severe Hidradenitis Suppurativa Treated with Secukinumab: A Real-World Study
Dermatology and Therapy|2024
22 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Thomas A.E. Platts‐Mills
University of Virginia
2
Rudolf Valenta
Medical University of Vienna
3
Stephen R. Durham
Imperial College London
4
Jean Bousquet
Charité - Universitätsmedizin Berlin
5
Johannes Ring
Technical University of Munich
6
Julia A. Segre
National Human Genome Research Institute
7
Giorgio Walter Canonica
Humanitas University
8
Ghazala Khan
University of Wales
9
Torsten Zuberbier
Humboldt-Universität zu Berlin
10
Richard F. Lockey
University of South Florida

Papers

1
Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use
Clinical and Experimental Dermatology|1994
5.5k cit.
2
Topographical and Temporal Diversity of the Human Skin Microbiome
Science|2009
3k cit.
3
Eosinophilic Inflammation in Asthma
New England Journal of Medicine|1990
2.5k cit.
4
Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis
Genome Research|2012
1.8k cit.
5
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
New England Journal of Medicine|2008
1.5k cit.
6
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
Allergy|2018
1.4k cit.
7
Long-Term Clinical Efficacy of Grass-Pollen Immunotherapy
New England Journal of Medicine|1999
1.4k cit.
8
INCIDENCE AND SEVERITY OF ANAPHYLACTOID REACTIONS TO COLLOID VOLUME SUBSTITUTES
The Lancet|1977
1.3k cit.
9
Topographic diversity of fungal and bacterial communities in human skin
Nature|2013
1.2k cit.
10
Biogeography and individuality shape function in the human skin metagenome
Nature|2014
1.2k cit.

Reagents for Allergic Rhinitis and Sensitization

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 65

Phospho-Rb (Ser807/811) (D20B12) Rabbit Monoclonal Antibody (Pacific Blue™ Conjugate)

#75864$493
View Evidence →
Agilent/Dako

Polyclonal Rabbit Anti- PGP 9.5

#PGP9.5
View Evidence →
Cell Signaling TechnologyEvidence 65

alpha-Parvin (D7F9) Rabbit Monoclonal Antibody

#8190$175,384
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 66

Phospho-Stat1 (Tyr701) (58D6) Rabbit Monoclonal Antibody (Alexa Fluor® 555 Conjugate)

Cited in 8 papers
#8183$493
View Evidence →
Cell Signaling TechnologyEvidence 64

Clathrin Heavy Chain (D3C6) Rabbit Monoclonal Antibody (BSA and Azide Free)

Cited in 5 papers
#38736$865
View Evidence →
R and D SystemsEvidence 60

Human UbcH5/UBE2D Polyclonal Ab

#A-615
View Evidence →